Submission Deadline
21 May 2022 (Vol 45 , Iss 04 )

Upcoming Publication
31 May 2022 (Vol 45 , Iss 03 )

Journal ID : TMJ-08-01-2022-10980
Download [This article belongs to Volume - 45, Issue - 01]
Total View : 353

Title : Adenoid Cystic Carcinoma of the Head and Neck Survival Analysis and Oncologic Outcome Single Institute Experience

Abstract :

To presents our experience, in diagnosis and management of ACC of the head and neck. This is a retrospective review of 57 patients with ACC managed during the period from January 2011 to January 2016. Data about the characteristics and management of the disease were recorded. All patients were followed up to detect the development of local recurrence and distant metastasis and their management. The mean age was 45.5±15.1, with a female-to-male ratio of 1.5:1. The minor salivary glands were affected in 61.4% of cases. Four patients (7%) were metastatic at presentation. The main presenting symptom was swelling, followed by pain. Surgical resection was performed in 48 patients (84.2%) followed by adjuvant radiotherapy in 36 of them. Four patients received radical radiotherapy. Treatment failed in 3 patients. Recurrences were recorded in 21 out of the 50 cured patients; 9 had locoregional recurrence, 9 had distant metastases, and 3 had both. The overall survival (OS) and disease-free survival (DFS) at three years were 79% and 57.1%, respectively. Surgical resection improved OS (p< 0.001). Advanced T-stage, lymph node invasion, solid tumors, close or positive margins worsened OS. Adjuvant radiotherapy was associated with better DFS (p = 0.003), while solid tumors were associated with worse DFS. Despite aggressive management with radical surgery and adjuvant radiotherapy, recurrence affects 42% of the patients within three years. Patients with unrespectable tumors have a poor prognosis. Adjuvant radiotherapy improves DFS but not OS.

Full article
//